JPMA Charter of Corporate Behavior
Pharmaceutical companies engage in business activities based on mutual and fair competition through market economies, and are expected to pursue life sciences based on a high degree of ethicality as life science-related companies responsible for the cutting edge of health care. The Japan Pharmaceutical Manufacturers Association (JPMA) drew up the JPMA Charter of Corporate Behavior in November 1997 as a set of industry self-regulations adopted by member companies to humbly reflect on past experience and ensure members move forward in the right direction. The Code was subsequently revised in November 2004 and further revisions were made in March 2011, taking into consideration the changing times. By complying with this Charter of Corporate Behavior, member companies resolve to gain trust and empathy from society and to create prospects for the future.